Subscribe Become an Author Sign Up Log In

Nanna Therapeutics (formerly Bactevo)

Company
Founded
2012
Status
Private
Geography
United Kingdom based
Funding
$1.85 M

About

Bactevo has built a unique and game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Utilising its paradigm shift in the speed, efficiency and quality of drug discovery, as well as massively enhancing safety profiling to improve clinical success, Bactevo is developing breakthrough medicines for the treatment of diseases that involve defects in mitochondrial function, such as MELAS and LHON, as well as diseases of the central nervous system, such as Parkinson’s, Alzheimer’s and Amyotrophic Lateral Sclerosis (ALS).

Business model
  • Software as a Service / AI as Service (SaaS, AIaaS)
Therapeutic focus
  • Cardiovascular
  • Metabolics
  • Neuroscience
Data type used for modelling
  • HTS and HCS data
Drug Discovery Strategy
  • Structure Based Drug Discovery (SBDD)
Product type
  • Small molecules
Research focus
  • Lead Discovery
  • Preclinical Development

Investing history

2017Unknown Round1.85

Industry Partnerships

YearPartnerFocus
2018Boehringer Ingelheimidentify novel small molecule lead compounds